In a recent article published in PLOS One, researchers determined whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the coronavirus disease 2019 (COVID-19) pandemic. Study: Impact of COVID-19 pandemic on pharmacologic treatment of patients newly diagnosed with osteoporosis. Image Credit: fizkes/Shutterstock/com Background Nearly 10 million individuals (≥50 years old)…